Lukas Pekar
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
-
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 23
-
- Glycosylation and Glycoproteins Research 7
- Protein purification and stability 7
- Viral Infectious Diseases and Gene Expression in Insects 3
- Co-authors
- Stefan Zielonka (26 shared papers)Simon Krah (19 shared papers)Bernhard Valldorf (7 shared papers)Lars Toleikis (13 shared papers)Steffen C. Hinz (2 shared papers)Harald Kolmar (12 shared papers)Achim Doerner (6 shared papers)Andreas Evers (13 shared papers)
- Journals
- mAbs (9 papers)Frontiers in Immunology (3 papers)Protein Science (3 papers)Biological Chemistry (3 papers)The Journal of Immunology (2 papers)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Lukas Pekar
25 papers receiving 371 citations
Peers
Comparison fields: 5 of 35
- Radiology, Nuclear Medicine and Imaging 280
- Immunology 121
- Oncology 118
- Biotechnology 40
- Molecular Biology 188
Countries citing papers authored by Lukas Pekar
This map shows the geographic impact of Lukas Pekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas Pekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas Pekar more than expected).
Fields of papers citing papers by Lukas Pekar
This network shows the impact of papers produced by Lukas Pekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas Pekar. The network helps show where Lukas Pekar may publish in the future.
Co-authors
The 25 scholars most cited alongside Lukas Pekar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 85 | |
| 2 | 2020 | 36 | |
| 3 | 2020 | 29 | |
| 4 | 2022 | 27 | |
| 5 | 2022 | 26 | |
| 6 | 2020 | 24 | |
| 7 | 2023 | 20 | |
| 8 | 2022 | 19 | |
| 9 | 2023 | 16 | |
| 10 | 2021 | 16 | |
| 11 | 2024 | 14 | |
| 12 | 2023 | 14 | |
| 13 | 2023 | 14 | |
| 14 | 2024 | 12 | |
| 15 | 2024 | 5 | |
| 16 | 2024 | 5 | |
| 17 | 2023 | 4 | |
| 18 | 2025 | 4 | |
| 19 | 2023 | 3 | |
| 20 | 2024 | 3 |
About Lukas Pekar
Lukas Pekar is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology, Oncology, Immunology and Biotechnology, having authored 28 papers that have together received 382 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (23 papers), CAR-T cell therapy research (9 papers), Glycosylation and Glycoproteins Research (7 papers), Protein purification and stability (7 papers), Immune Cell Function and Interaction (6 papers), Transgenic Plants and Applications (5 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers) and T-cell and B-cell Immunology (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (280 citations), Immunology (121 citations), Oncology (118 citations), Biotechnology (40 citations) and Molecular Biology (188 citations). Lukas Pekar has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Stefan Zielonka, Simon Krah, Bernhard Valldorf, Lars Toleikis, Steffen C. Hinz, Harald Kolmar, Achim Doerner, Andreas Evers, Michael Hust and Giulio Russo. Their work appears in journals such as mAbs, Frontiers in Immunology, Protein Science, Biological Chemistry and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.